An FDA advisory panel is expected Thursday to recommend authorization of the COVID-19 vaccine developed by Moderna. It could be in states by Monday.
Author: Karen Weintraub, USA TODAY
German scientist Özlem Türeci was focused on cancer at BioNTech, then came COVID-19. It was her ‘duty’ to help develop a vaccine.
When Özlem Türeci, co-founder of BioNTech, first heard about the novel coronavirus, she knew her company would have to work on a vaccine to fight it.
‘A historic event for humanity’: US reaches turning point in fight against COVID-19 as FDA authorizes Pfizer vaccine
The FDA authorization clears the way for Americans to begin receiving Pfizer’s vaccine. First in line: Health care workers and nursing home residents.
The Gates Foundation adds $250M gift to fight COVID-19 worldwide: Melinda Gates explains why
In a wide-ranging interview with USA TODAY, Melinda Gates talks about the goal of her new donation, global health, education and finding hope.
‘Very inconsistent’: 2 allergic reactions in the UK to COVID-19 vaccine puzzle researchers
British regulators advised people with severe allergies not to take Pfizer vaccine. One US researcher says that would be a ‘showstopper’ here.
Continuing COVID-19 vaccine trials may put some volunteers at unnecessary risk. Is that ethical?
The success of candidate vaccines by Pfizer/BioNTech and Moderna raises ethical questions about continuing placebo trials in which some may get sick.
Moderna becomes second company to request emergency FDA authorization for COVID-19 vaccine candidate
Moderna will be the second coronavirus vaccine maker to request authorization from the government after similarly positive trial results for Pfizer.
Pfizer and Moderna use mRNA in their COVID-19 vaccines. This never-before-used technology could transform how science fights diseases.
Though messenger RNA technology like Pfizer, Moderna use hasn’t grabbed headlines before now, some researchers have been working on it for decades.
COVID-19 vaccine should be ready for most vulnerable late this year, for everyone by spring, HHS Secretary Alex Azar says
During a rare CDC public briefing, HHS Secretary Alex Azar on Wednesday outlined a timeline for the COVID-19 vaccine and pledged it would be safe.
Nevada man’s COVID-19 reinfection, the first in the US, is ‘yellow caution light’ about risk of coronavirus
A 25-year-old Nevada man is the first American confirmed to have been infected twice with COVID-19. He was sicker the second time.